Background: Cutaneous adverse effects of Teriflunomide have been rarely reported.
Objective and methods: We report a relapsing remitting multiple sclerosis patient that developed palmar pustular psoriasis within one month of teriflunomide initiation.
Results: Our patient required discontinuation of teriflunomide due to frequent recurrence of pustules with continuous need of local steroid treatment and resolved completely after teriflunomide discontinuation.
Conclusion: Pustular psoriasis can be triggered by medications but has not been previously reported in association with teriflunomide treatment, to the best of our knowledge.
Keywords: Adverse effect; Disease-modifying therapy; Multiple sclerosis; Pustular psoriasis; Teriflunomide.
Copyright © 2018. Published by Elsevier B.V.